IPP Bureau
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
By IPP Bureau - April 17, 2026
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
NIFTY Pharma shows stable trend amid cautious market sentiment
By IPP Bureau - April 17, 2026
Muted movement reflects consolidation phase as investors await earnings triggers
DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
By IPP Bureau - April 17, 2026
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
By IPP Bureau - April 17, 2026
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Inter-ministerial study to track zoonotic spillover risks in India
By IPP Bureau - April 17, 2026
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
India pushes policy action on adolescent nutrition as obesity concerns rise
By IPP Bureau - April 17, 2026
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
By IPP Bureau - April 17, 2026
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
By IPP Bureau - April 17, 2026
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice
By IPP Bureau - April 17, 2026
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Moberg Pharma reports 2025 annual results, maintains strong cash position
By IPP Bureau - April 17, 2026
The company reported net revenue of SEK 13.5 million for the full year 2025
Experts push for preventive, equitable haemophilia care at IHC X Summit
By IPP Bureau - April 17, 2026
The national platform brought together healthcare professionals, patient advocates, and stakeholders
NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
By IPP Bureau - April 16, 2026
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
By IPP Bureau - April 16, 2026
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Zydus Wellness appoints Adhir Anand as Head of Media & Digital
By IPP Bureau - April 16, 2026
Former Wavemaker executive to lead media strategy and digital transformation agenda
Former health minister Dr Harsh Vardhan visits Wadi Surgicals’ nitrile glove facility at AMTZ
By IPP Bureau - April 16, 2026
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
